Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Zolmitriptan by PassPort Technologies Inc (USA) for Migraine: Likelihood of Approval
Zolmitriptan is under clinical development by PassPort Technologies Inc (USA) and currently in Phase I for Migraine. According to GlobalData,...